These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24649377)

  • 1. Colicin E2 Expression in Lactobacillus brevis DT24, A Vaginal Probiotic Isolate, against Uropathogenic Escherichia coli.
    Trivedi D; Jena PK; Seshadri S
    ISRN Urol; 2014; 2014():869610. PubMed ID: 24649377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial Purification and Characterization of a Bacteriocin DT24 Produced by Probiotic Vaginal Lactobacillus brevis DT24 and Determination of its Anti-Uropathogenic Escherichia coli Potential.
    Trivedi D; Jena PK; Patel JK; Seshadri S
    Probiotics Antimicrob Proteins; 2013 Jun; 5(2):142-51. PubMed ID: 26782739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro effect of vaginal lactobacilli on the growth and adhesion abilities of uropathogenic Escherichia coli.
    Leccese Terraf MC; Juarez Tomás MS; Rault L; Le Loir Y; Even S; Nader-Macías MEF
    Arch Microbiol; 2017 Jul; 199(5):767-774. PubMed ID: 28280842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of probiotic vaginal lactobacilli on in vitro adhesion of urogenital pathogens to vaginal epithelial cells.
    Zárate G; Nader-Macias ME
    Lett Appl Microbiol; 2006 Aug; 43(2):174-80. PubMed ID: 16869901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and Sensitivity of Vaginal and Probiotic
    Singhal L; Gupta V; Gupta M; Goel P; Chander J
    J Lab Physicians; 2020 Aug; 12(2):111-114. PubMed ID: 32905311
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro activity of commercial probiotic Lactobacillus strains against uropathogenic Escherichia coli.
    Delley M; Bruttin A; Richard M; Affolter M; Rezzonico E; Brück WM
    FEMS Microbiol Lett; 2015 Jul; 362(13):fnv096. PubMed ID: 26078118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of profertility effect of probiotic Lactobacillus plantarum 2621 in a murine model.
    Bhandari P; Prabha V
    Indian J Med Res; 2015 Jul; 142(1):79-84. PubMed ID: 26261170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colicins prevent colonization of urinary catheters.
    Trautner BW; Hull RA; Darouiche RO
    J Antimicrob Chemother; 2005 Aug; 56(2):413-5. PubMed ID: 15980093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of vaginal Lactobacillus paracasei CRL 1289 against urogenital infection produced by Staphylococcus aureus in a mouse animal model.
    Zárate G; Santos V; Nader-Macias ME
    Infect Dis Obstet Gynecol; 2009; 2009():48358. PubMed ID: 17485818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriocin synthesis in uropathogenic and commensal Escherichia coli: colicin E1 is a potential virulence factor.
    Smajs D; Micenková L; Smarda J; Vrba M; Sevčíková A; Vališová Z; Woznicová V
    BMC Microbiol; 2010 Nov; 10():288. PubMed ID: 21078157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urogenital pathogen inhibition and compatibility between vaginal Lactobacillus strains to be considered as probiotic candidates.
    Juárez Tomás MS; Saralegui Duhart CI; De Gregorio PR; Vera Pingitore E; Nader-Macías ME
    Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):399-406. PubMed ID: 21862199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the potential of colicins to prevent extraluminal contamination of urinary catheters by Escherichia coli.
    Roy SM; Riley MA
    Int J Antimicrob Agents; 2019 Nov; 54(5):619-625. PubMed ID: 31284040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence of Lactobacillus crispatus to vaginal epithelial cells from women with or without a history of recurrent urinary tract infection.
    Kwok L; Stapleton AE; Stamm WE; Hillier SL; Wobbe CL; Gupta K
    J Urol; 2006 Nov; 176(5):2050-4; discussion 2054. PubMed ID: 17070251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotic characterization of
    Jang HJ; Lee NK; Paik HD
    Food Sci Biotechnol; 2019 Oct; 28(5):1521-1528. PubMed ID: 31695951
    [No Abstract]   [Full Text] [Related]  

  • 15. Vaginal Lactobacillus isolates inhibit uropathogenic Escherichia coli.
    Atassi F; Brassart D; Grob P; Graf F; Servin AL
    FEMS Microbiol Lett; 2006 Apr; 257(1):132-8. PubMed ID: 16553843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in vitro activity of vaginal Lactobacillus with probiotic properties against Candida.
    Strus M; Kucharska A; Kukla G; Brzychczy-Włoch M; Maresz K; Heczko PB
    Infect Dis Obstet Gynecol; 2005 Jun; 13(2):69-75. PubMed ID: 16011996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrogen peroxide production and resistance to nonoxinol-9 in Lactobacillus spp. isolated from the vagina of reproductive-age women.
    Angeles-López M; García-Cano Ramos E; Aquino Santiago C
    Rev Latinoam Microbiol; 2001; 43(4):171-6. PubMed ID: 17061505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some probiotic properties of
    Lashani E; Davoodabadi A; Soltan Dallal MM
    Vet Res Forum; 2020; 11(2):121-126. PubMed ID: 32782740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteriocin PJ4 from probiotic lactobacillus reduced adipokine and inflammasome in high fat diet induced obesity.
    Bai L; Kumar S; Verma S; Seshadri S
    3 Biotech; 2020 Aug; 10(8):355. PubMed ID: 32766096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technological and Probiotic Traits of the Lactobacilli Isolated From Vaginal Tract of the Healthy Women for Probiotic Use.
    Bouridane H; Sifour M; Idoui T; Annick L; Thonard P
    Iran J Biotechnol; 2016 Sep; 14(3):192-201. PubMed ID: 28959336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.